251 related articles for article (PubMed ID: 18992912)
1. Expression and prognostic significance of the alpha B-crystallin gene in human hepatocellular carcinoma.
Tang Q; Liu YF; Zhu XJ; Li YH; Zhu J; Zhang JP; Feng ZQ; Guan XH
Hum Pathol; 2009 Mar; 40(3):300-5. PubMed ID: 18992912
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis.
Fujii T; Nomoto S; Koshikawa K; Yatabe Y; Teshigawara O; Mori T; Inoue S; Takeda S; Nakao A
Hepatology; 2006 Jun; 43(6):1267-75. PubMed ID: 16628605
[TBL] [Abstract][Full Text] [Related]
3. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH
Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD147 as a significantly unfavorable prognostic factor in hepatocellular carcinoma.
Zhang Q; Zhou J; Ku XM; Chen XG; Zhang L; Xu J; Chen GS; Li Q; Qian F; Tian R; Wen N; Chen ZN
Eur J Cancer Prev; 2007 Jun; 16(3):196-202. PubMed ID: 17415090
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma.
Zhang SH; Xu AM; Chen XF; Li DH; Sun MP; Wang YJ
Hum Pathol; 2008 Dec; 39(12):1827-34. PubMed ID: 18715617
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of XPO4 is associated with poor prognosis in hepatocellular carcinoma.
Liang XT; Pan K; Chen MS; Li JJ; Wang H; Zhao JJ; Sun JC; Chen YB; Ma HQ; Wang QJ; Xia JC
J Gastroenterol Hepatol; 2011 Mar; 26(3):544-9. PubMed ID: 21332550
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of osteopontin independently correlates with vascular invasion and poor prognosis in patients with hepatocellular carcinoma.
Korita PV; Wakai T; Shirai Y; Matsuda Y; Sakata J; Cui X; Ajioka Y; Hatakeyama K
Hum Pathol; 2008 Dec; 39(12):1777-83. PubMed ID: 18701136
[TBL] [Abstract][Full Text] [Related]
8. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
[TBL] [Abstract][Full Text] [Related]
9. Alpha B-crystallin, a new independent marker for poor prognosis in head and neck cancer.
Chin D; Boyle GM; Williams RM; Ferguson K; Pandeya N; Pedley J; Campbell CM; Theile DR; Parsons PG; Coman WB
Laryngoscope; 2005 Jul; 115(7):1239-42. PubMed ID: 15995513
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma.
Ma S; Guan XY; Lee TK; Chan KW
Hum Pathol; 2007 Aug; 38(8):1201-6. PubMed ID: 17442377
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Ets-1 proto-oncogene is linked to cell differentiation of human hepatocellular carcinoma.
Kanda K; Nakayama T; Onizuka S; Tomioka T; Kanematsu T
Hepatogastroenterology; 2002; 49(45):747-51. PubMed ID: 12063983
[TBL] [Abstract][Full Text] [Related]
12. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
[TBL] [Abstract][Full Text] [Related]
13. Correlations of the expression of vascular endothelial growth factor B and its isoforms in hepatocellular carcinoma with clinico-pathological parameters.
Kanda M; Nomoto S; Nishikawa Y; Sugimoto H; Kanazumi N; Takeda S; Nakao A
J Surg Oncol; 2008 Sep; 98(3):190-6. PubMed ID: 18537151
[TBL] [Abstract][Full Text] [Related]
14. Survivin gene expression in chronic liver disease and hepatocellular carcinoma.
Montorsi M; Maggioni M; Falleni M; Pellegrini C; Donadon M; Torzilli G; Santambrogio R; Spinelli A; Coggi G; Bosari S
Hepatogastroenterology; 2007; 54(79):2040-4. PubMed ID: 18251156
[TBL] [Abstract][Full Text] [Related]
15. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].
Yuan Z; Fan J; Wu ZQ; Zhou J; Qiu SJ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1256-9. PubMed ID: 17686260
[TBL] [Abstract][Full Text] [Related]
16. Association of NET-1 gene expression with human hepatocellular carcinoma.
Chen L; Wang Z; Zhan X; Li DC; Zhu YY; Zhu J
Int J Surg Pathol; 2007 Oct; 15(4):346-53. PubMed ID: 17913940
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of ING2 gene and its clinicopathological significance in hepatocellular carcinoma.
Zhang HK; Pan K; Wang H; Weng DS; Song HF; Zhou J; Huang W; Li JJ; Chen MS; Xia JC
Cancer Lett; 2008 Mar; 261(2):183-92. PubMed ID: 18160212
[TBL] [Abstract][Full Text] [Related]
18. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
[TBL] [Abstract][Full Text] [Related]
19. Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.
Kuboki S; Shimizu H; Mitsuhashi N; Kusashio K; Kimura F; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Miyazaki M
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e157-64. PubMed ID: 17931370
[TBL] [Abstract][Full Text] [Related]
20. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]